Kiniksa Pharmaceuticals International (KNSA) Current Leases (2019 - 2026)
Kiniksa Pharmaceuticals International's (KNSA) quarterly Current Leases came in at $4.0 million in Q2 2026, up 59.08% YoY from $2.5 million in Q2 2025, and up 26.56% on a QoQ basis from $3.2 million in Q1 2026.
Kiniksa Pharmaceuticals International (KNSA) Current Leases (2019 - 2026) Analysis & Trends
Kiniksa Pharmaceuticals International (KNSA) has 8 years of Current Leases data on file, last reported at $4.0 million in Q2 2026.
- Quarterly Current Leases rose 59.08% year-over-year to $4.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $4.0 million (up 59.08% YoY) and the FY2025 annual result came in at $3.0 million, up 49.87% from the prior year.
- Current Leases rose to $4.0 million in Q2 2026, from $3.2 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $4.0 million in Q2 2026 to a low of $2.0 million in Q4 2024.
- A 5-year average of $2.8 million and a median of $2.6 million in 2025 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2024 — Current Leases tumbled 34.55% — and 2026, when it soared 59.08%.
- Tracing KNSA's Current Leases over 5 years: stood at $3.3 million in 2022, then slumped by 31.75% to $2.3 million in 2023, then decreased by 11.54% to $2.0 million in 2024, then surged by 49.87% to $3.0 million in 2025, then surged by 34.32% to $4.0 million in 2026.
- The last three Current Leases figures came in at $4.0 million (Q2 2026), $3.2 million (Q1 2026), and $3.0 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Kiniksa Pharmaceuticals International | 6.05 Bn | 5.53 Bn | 220.03 Mn | 4.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.01 Mn |
| Mar 31, 2026 | 3.17 Mn |
| Dec 31, 2025 | 2.99 Mn |
| Sep 30, 2025 | 2.70 Mn |
| Jun 30, 2025 | 2.52 Mn |
| Mar 31, 2025 | 2.29 Mn |
| Dec 31, 2024 | 1.99 Mn |
| Sep 30, 2024 | 2.03 Mn |
| Jun 30, 2024 | 2.09 Mn |
| Mar 31, 2024 | 2.28 Mn |
| Dec 31, 2023 | 2.25 Mn |
| Sep 30, 2023 | 2.31 Mn |
| Jun 30, 2023 | 2.24 Mn |
| Mar 31, 2023 | 3.48 Mn |
| Dec 31, 2022 | 3.30 Mn |
| Sep 30, 2022 | 3.27 Mn |
| Jun 30, 2022 | 3.34 Mn |
| Mar 31, 2022 | 3.31 Mn |
| Dec 31, 2021 | 3.38 Mn |
| Sep 30, 2021 | 3.25 Mn |